Increased cell proliferation is associated with genomic instability: Elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells

Mutagenesis

Volumn 18, Issue 3, 2003, Pages 243-247

  Stopper, Helga ^c   Schmitt, Elmar ^c   Gregor, Caroline ^c   Mueller, Stefan O ^a   Fischer, Wolfgang H ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MERCK KGAA   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; HYDROXYTAMOXIFEN;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE G2 PHASE; CELL DIVISION; CELL PROLIFERATION; CENTROMERE; CHROMOSOME BREAKAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE MUTATION; GENETIC STABILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOTHESIS; METAPHASE; MICRONUCLEUS; MITOSIS INHIBITION; OVARY CANCER; PRIORITY JOURNAL; TUMOR PROMOTION;

CELL DIVISION; ESTRADIOL; FEMALE; GENOMIC INSTABILITY; HUMANS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; OVARIAN NEOPLASMS;

EID: 0038731218     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/18.3.243     Document Type: Article

References (24)

1. Antoccia,A., Degerassi,F., Battistoni,A., Ciliutti,P. and Tanzarella,C. (1991) In vitro micronucleus test with kinetochore staining: evaluation of test performance. Mutagenesis, 6, 319-324.
2. Coibion,M., Kiss,R., Jossa,V., de Launoit,Y., Van Geloven,O., Malengreau,A., Mattheiem,W., Pasteels,J.L. and Paridaens,R. (1989) In vitro influence of estrdiol or progesterone on the thymidine labeling indices of human benign breast tumors. Anticancer Res., 9, 475-482.
3. Davis,C., Bhana,S., Shorrocks,A.J. and Martin,F.L. (2002) Oestrogens induce G(1) arrest in benzo[a] pyrene-treated MCF-7 breast cells whilst enhancing genotoxicity and clonogenic survival. Mutagenesis, 17, 431-438.
4. DuMond,J.W. and Roy,D. (2001) The inhibition of DNA repair capacity by stilbene estrogen in Leydig cells: its implications in the induction of instability in the testicular genome. Mutat. Res., 483, 27-33.
5. Eckert,I. and Stopper,H. (1996) Genotoxic effects induced by β-oestradiol in vitro. Toxicol. In Vitro, 10, 637-642.
6. Epstein,R.J. and Smith,P.J. (1988) Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs. Cancer Res., 48, 297-303.
7. Feigelson,H.S. and Henderson,B.E. (1996) Estrogens and breast cancer. Carcinogenesis, 17, 2279-2284.
8. Fenech,M. (1993) The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res., 285, 35-44.
9. Fenech,M. and Neville,S. (1992) Conversion of excision-repairable DNA lesions to micronuclei within one cell cycle in human lymphocytes. Environ. Mol. Mutagen., 19, 27-36.
10. Fischer,W.H., Keiwan,A., Schmitt,E. and Stopper,H. (2001) Increased formation of micronuclei after hormonal stimulation of cell proliferation in human breast cancer cells. Mutagenesis, 16, 209-212.
11. Highman,B., Greenman,D.L., Norvell,M.J., Farmer,J. and Shellenberger,T.E. (1980) Neoplastic and preneoplastic lesions induced in female C3H mice by diets containing diethylstilbestrol or 17 beta-estradiol. J. Environ. Pathol. Toxicol., 4, 81-95.
12. Highman,B., Roth,S.I. and Greenman,D.L. (1981) Osseous changes and osteosarcomas in mice continuously fed diets containing diethylstilbestrol or 17 beta-estradiol. J. Natl Cancer Inst., 67, 653-662.
13. Klotz,D.M., Beckman,B.S., Hill,S.M., McLachlan,J.A., Walters,M.R. and Arnold,S.F. (1996) Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environ. Health Perspect., 104, 1084-1089.
14. Kong,L.Y., Szaniszlo,P., Albrecht,T. and Liehr,J.G. (2000) Frequency and molecular analysis of hprt mutations induced by estradiol in Chinese hamster V79 cells. Int. J. Oncol., 17, 1141-1149.
15. Liehr,J.G. (2000) Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev., 21, 40-54.
16. Liehr,J.G., Stancel,G.M., Chorich,L.P., Bousfield,G.R. and Ulubelen,A.A. (1986) Hormonal carcinogenesis: separation of estrogenicity from carcinogenicity. Chem. Biol. Interact., 59, 173-184.
17. Nagasawa,H., Mori,T. and Nakajima,Y. (1980) Long-term effects of progesterone or diethylstilbestrol with or without estrogen after maturity on mammary tumorigenesis in mice. Eur. J. Cancer, 16, 1583-1589.
18. Roy,D. and Liehr,J.G. (1999) Estrogen, DNA damage and mutations. Mutat. Res., 424, 107-115.
19. Schuler,M., Hasegawar,L., Parks,R., Metzler,M. and Eastmond,D.A. (1998) Dose-response studies of the induction of hyperdiploidy and polyploidy by diethylstilbestrol and 17β-estradiol in cultured human lymphocytes using multicolor fluorescence in situ hybridization. Environ. Mol. Mutagen., 31, 263-273.
20. Suganuma,M., Kawabe,T., Hori,H., Funabiki,T. and Okamoto,T. (1999) Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation. Cancer Res., 59, 5887-5891.
21. Weinert,T. (1998) DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell, 94, 555-558.
22. Wheeler,W.J., Cherry,L.M., Downs,T. and Hsu,T.C. (1986) Mitotic inhibition and aneuploidy induction by naturally occurring and synthetic estrogens in chinese hamster cells in vitro. Mutat. Res., 171, 31-41.
23. Wingo,P.A., Tong,T. and Bolden,S. (1995) Cancer statistics, 1995. CA Cancer J. Clin., 45, 8-30.
24. Zhou,B.-B.S., Chaturvedi,P., Spring,K., Scott,S.P., Johanson,R.A., Mishra,R., Mattern,M.R., Winkler,J.D. and Khanna,K.K. (2000) Caffeine abolishes the mammalian G2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem., 275, 10342-10348.